Avalyn Pharma Inc.

Bioscience & Disease Healthcare Systems

@AvalynPharma Website LinkedIn Seattle, Washington, USA

About Avalyn Pharma Inc.

Avalyn Pharma Inc. is involved in the biotechnology and healthcare sectors, focusing on the development of inhaled therapies for pulmonary fibrosis.

Business Information

Target Customers

healthcare providers pharmaceutical companies research institutions

Industry Categories

Bioscience & Disease Healthcare Systems

Business Model

Revenue Model Pharmaceutical sales

Pricing Strategy Value-based pricing

Sales Channels direct sales, partnerships with healthcare providers

Funding Timeline

Round	Date	Amount	Investors
Series D	Jul 22, 2025	$100.0M	Unknown

Founders

No founder information available.

Investors

No investor information available.

Recent Mentions

Raising.fi @raisingfi

Jul 22, 2025

New Raise 🏛️ Company: Avalyn Pharma Inc. 🔗 Website: https://t.co/CmQKcCmeYn 📊 Amount: $100 Million 🔄 Round: Series D 🧮 Valuation: N/A ⚙️ Industry: Biotechnology, Healthcare

View on Twitter

Novo Holdings @novoholdings

Jul 22, 2025

We are pleased to participate in Avalyn Pharma’s $100M oversubscribed Series D funding round, which will support the advancement of the company’s inhaled therapies for pulmonary fibrosis. Avalyn’s pipeline, including inhaled formulations of pirfenidone and nintedanib, has the https://t.co/suU3MSsD1C

View on Twitter

Similar Startups

Avammune Therapeutics

86% match

Avammune Therapeutics is a biopharmaceutical company focused on small molecule drug discovery and de...

Alpheus Medical

86% match

A private, clinical-stage oncology company focused on developing innovative therapies for cancer tre...

Allay Therapeutics

85% match

Allay Therapeutics is pioneering ultra-sustained analgesic products to transform post-surgical pain ...

Incannex Healthcare Inc.

85% match

Incannex Healthcare Inc. is a biotechnology company focused on developing innovative cannabinoid-bas...